Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer

被引：0
|
作者：
Tyerman, Zachary [1 ]
Ambler, Emily [2 ]
Schlick, Cary Jo R. [1 ]
Nwajei, Felix [4 ]
Chawla, Akhil [1 ,2 ,3 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA
[2] Northwestern Univ, Div Surg Oncol, Dept Surg, Northwestern Med Reg Med Grp,Feinberg Sch Med, Chicago, IL 60190 USA
[3] Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[4] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA
来源：
JOURNAL OF CANCER METASTASIS AND TREATMENT | 2022年 / 8卷
关键词：
Pancreatic cancer; circulating tumor DNA; prognosis; survival; DUCTAL ADENOCARCINOMA; DIAGNOSIS; MARKER; RESISTANCE; MUTATIONS; CA19-9; PLASMA; BLOOD; SERUM;
D O I：
10.20517/2394-4722.2022.20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: The measurement of circulating tumor DNA (ctDNA) has been studied in several malignancies, including metastatic pancreatic cancer, but less is known about its utility in monitoring treatment response and recurrence in resectable pancreatic cancer. Methods: We conducted a systematic review of the literature examining the association of ctDNA with overall survival (OS) and disease-free survival. Results: Five articles met our exclusion criteria. Baseline and/or postoperative ctDNA was found to be associated with decreased OS and recurrence-free survival. Discussion: ctDNA has the potential to be used as a prognostic biomarker and to guide therapy in resectable pancreatic cancer.
引用
收藏
页数：9
相关论文
共 50 条
  • [41] Predicting long-term prognosis using targeted cell free DNA sequencing in resectable pancreatic cancer patients.
    Song, Bo
    Tang, Ling Fung Paul
    Zhao, Grace Q.
    Lin, Shengrong
    Ying, Kang
    Jin, Gang
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
    Liu, Zheng
    Shi, Zhongyi
    Jiang, Wenchao
    Shen, Zhenbin
    Chen, Weidong
    Shen, Kuntang
    Sun, Yihong
    Tang, Zhaoqing
    Wang, Xuefei
    MEDCOMM, 2025, 6 (02):
  • [43] Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
    Groot, Vincent P.
    Mosier, Stacy
    Javed, Ammar A.
    Teinor, Jonathan A.
    Gemenetzis, Georgios
    Ding, Ding
    Haley, Lisa M.
    Yu, Jun
    Burkhart, Richard A.
    Hasanain, Alina
    Debeljak, Marija
    Kamiyama, Hirohiko
    Narang, Amol
    Laheru, Daniel A.
    Zheng, Lei
    Lin, Ming-Tseh
    Gocke, Christopher D.
    Fishman, Elliot K.
    Hruban, Ralph H.
    Goggins, Michael G.
    Molenaar, I. Quintus
    Cameron, John L.
    Weiss, Matthew J.
    Velculescu, Victor E.
    He, Jin
    Wolfgang, Christopher L.
    Eshleman, James R.
    CLINICAL CANCER RESEARCH, 2019, 25 (16) : 4973 - 4984
  • [44] Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer
    Comino-Mendez, Inaki
    Turner, Nicholas
    CANCER DISCOVERY, 2017, 7 (12) : 1368 - 1370
  • [45] Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA).
    Zeineddine, Mohammad A.
    Zeineddine, Fadl A.
    Yousef, Abdelrahman M. G.
    Dansby, Julia
    White, Michael
    Overman, Michael J.
    Newhook, Timothy E.
    Dasari, Arvind
    Fournier, Keith F.
    Raghav, Kanwal Pratap Singh
    Uppal, Abhineet
    Shen, John Paul Y. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 226 - 226
  • [46] Advance of Circulating Tumor Cells in the Prognosis and Management of Endometrial Cancer
    Li, Hongli
    Liu, Chang
    Wang, Jing
    Xu, Feixue
    Yang, Yongxiu
    Liang, Xiaolei
    CANCER INVESTIGATION, 2024, 42 (10) : 845 - 857
  • [47] Comparative levels of KRAS mutations circulating tumor DNA for association with overall survival in patients with non-resectable pancreatic cancer
    Johansen, Julia S.
    Vibat, Cecile Rose T.
    Hancock, Saege
    Hassaine, Latifa
    Samuelsz, Errin
    Chen, Inna
    Collisson, Eric A.
    Calatayud, Dan
    Jensen, Benny V.
    Hasselby, Jane Preuss
    Lu, Timothy T.
    Poole, Jason C.
    Melnikova, Vlada
    Erlander, Mark G.
    CANCER RESEARCH, 2015, 75
  • [48] Management of Borderline Resectable Pancreatic Cancer
    Lal, Alysandra
    Christians, Kathleen
    Evans, Douglas B.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (02) : 359 - +
  • [49] Evolution of the Management of Resectable Pancreatic Cancer
    Tsai, Susan
    Erickson, Beth A.
    Dua, Kulwinder
    Ritch, Paul S.
    Tolat, Parag
    Evans, Douglas B.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (09) : 772 - 778
  • [50] Management of borderline resectable pancreatic cancer
    Mahipal, Amit
    Frakes, Jessica
    Hoffe, Sarah
    Kim, Richard
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (10) : 241 - 249
12345